42nd Annual Meeting

Annual Meeting Theme:
Advancing Rigorous and Ethical Trials in the Pandemic Era


May 17-20, 2021



Virtual Meeting Platform

Platform Vendor: Vision Matrix

Vision Matrix's unique blend of large-scale creativity with meticulous project management produces turn-key solutions for our clients at a remarkable value. Each production provides us with a new vision, a new challenge, and a new opportunity to provide unique results that not only meet, but consistently exceed, our clients' expectations.

Vision Matrix operates with the best that advanced equipment has to offer, and with a level of imagination and competency you won't find elsewhere. Vision Matrix brings your visions to light.

Meeting | Overview

About the Annual Meeting
The Annual Meeting of the Society for Clinical Trials is a multidisciplinary program with broad participation. The Meeting brings together the clinical trials community from academia, the pharmaceutical and device industries, government agencies, medical groups and centers and clinical research entities.

Highlights include:

  • Plenary sessions, topical sessions and contributed presentations (both live and on-demand) on COVID-19 studies, the impact of COVID-19 on trials, along with many other clinical trial related topics
  • In-conference educational workshops, offering guidance on both classical and topical issues in clinical trials
  • Annual Thomas C. Chalmers Student Scholarship and Sylvan Green Award competitions
  • Discussion of timely issues and research experiences among colleagues in the field of clinical trials
  • Presentation of the 2020 David Sackett Trial of the Year Award
  • Presentation of the SCT Class of 2021 Fellows

This year’s meeting will be Virtual.

The program is being developed by the SCT Program and Education Committees, and promises to make the best of this unique opportunity for global collaboration.

We look forward to welcoming you!

About the Society
The Society for Clinical Trials (SCT) is an educational, charitable, and scientific organization whose mission is to work internationally to advance human health through advocating the use of clinical trials, leading the development and dissemination of optimal methods and practices in clinical trials, and educating and developing all clinical trial professionals. We are a society with representation from academia, industry, government and non-profit research and advocacy groups. Our community consists of clinical investigators, biostatisticians, project managers, IT specialists, clinical research associates and people from other clinical trials specialties. Our membership spans the globe with representation from 34 different countries.

Find out more: http://www.sctweb.org/

registration | Pricing


Discounted Fees
Discounted Fee of $200 available for attendees from developing countries. Please email registration@sctweb.org for more information about discounts or any other questions.

Registration Policy
All payments must be made in USD ($) to ensure that the full amount is received. Entry to the conference will not be permitted unless full payment has been received.

Cancellation Policy
Written cancellations received via email to registration@sctweb.org by May 10th will be refunded less a $50 administrative fee. There will be no refunds issued after May 10th. Failure to attend without notice will not result in a refund.

Program | At a Glance

We are delighted to release the provisional program for the 42nd annual meeting of the Society which will be held virtually and will run 17-20 May. The theme for the 42nd Annual Meeting is "Advancing Rigorous and Ethical Trials in the Pandemic Era". The Program includes two exciting keynote talks, over 20 thematic sessions and over 100 contributed presentations on diverse topics. Contributors come from a wide range of backgrounds and disciples representing the range of stakeholders in clinical trial research and conduct. Clicking on the bold red titles will download session details where available. Please note that the program is not fully confirmed and speakers and timing particularly within individual sessions may be subject to some change. Note all times are Eastern.
SCT Annual Meeting - Monday, May 17, 2021
9:00 - 10:00 New Member Welcome & Orientation Session
10:00 - 11:30 Welcome - SCT President - Dr. Susan Halabi
Founders Lecture Keynote
Dr. Lane - Conducting Clinical Research In The Setting Of An Outbreak: From HIV To Ebola To Covid-19
11:30 - 12:30 Session Proposal 1
Seema Shah & Charles Weijer
Ethics and future of human challenge trials with SARS-CoV-2 to speed vaccine development
Session Proposal 2
Qilu Yu
Managing Pragmatic Clinical Trials in the Time of COVID-19
Session Proposal 3
Sonia Jain
Design, Implementation, and Analysis of N-of-1 Clinical Trials
Session Proposal 4
SCT Committee Updates
12:30 - 1:00 Lunch
1:00 - 2:00 Contributed Sessions 1
Statistical Design I
Contributed Sessions 2
Statistical Analysis I
Contributed Sessions 3
Data Management I
Contributed Sessions 4
Study Co-ordination I

In-Conference Workshop 1

Mary Redman & Susan Halabi
Biomarker Driven Trials for Precision Medicine
2:00 - 3:00 Session Proposal 6
James Albert
Design and Implementation of a Vaccine Trial in a Pandemic – mRNA-1273 Phase I Trial
Session Proposal 7
Greg Ball
Different Clinical Trial Analyses for Different Stakeholders
Session Proposal 8
Saurabh Mukhopadhyay
Leveraging External Evidence in Clinical Research using Novel Statistical Methods
Session Proposal 9
Shahrul Mt-Isa
Benefit-Risk Assessment in Clinical Trials with Individual Patient Needs in Mind
3:00 - 3:30 Networking
SCT Annual Meeting - Tuesday, May 18, 2021
10:00 - 11:30 Curtis Meinert Keynote
Professor Martin Landray - “Better Trials for Better Health”
11:30 - 12:30 Session Proposal 10
Ashley Wegel
Adaptive COVID-19 Treatment Trial (ACTT) Data Management: Ensuring Success in a Constantly-Evolving, High-Demand Pandemic Environment
Session Proposal 11
Erinn Hade
Sample size re-estimation: Reflections on implementation and extensions to complex designs
Session Proposal 12
Jonathan Cook
The ASPIRE guidance on surgical placebo controls in randomised trials
Session Proposal 13
Lehana Thabane
12:30 - 1:00 Lunch
1:00 - 2:00 Chalmers Student Scholarship Finalists:
Subodh Selukar
Xiaoyu Tang
Siyun Yang
Contributed Sessions 5
Statistical Design II
Contributed Sessions 6
Outcomes I
Contributed Sessions 7
Study Co-ordination II

In-Conference Workshop 2

Sheng Luo
Design Clinical Trials with Multiple Endpoints: Methods and Applications
2:00 - 3:00 Session Proposal 14
Kert Viele
Bayesian Modeling in COVID-19 – Disease Modeling, Therapeutics, and Vaccines
Session Proposal 15
Janel Fedler
The Impact of COVID-19 on the Conduct of Trials in the NeuroNEXT Network
Session Proposal 16
Monica Taljaard
Pragmatic trials: key unresolved ethical issues and the need for guidance
Session Proposal 17
Susan Halabi
SCT New Committees and DMC Training Initiative
3:30 Reception for all members
SCT Annual Meeting - Wednesday, May 19, 2021
9:00 - 10:00 Presentation of the Class of 2021 Fellows
10:00 - 11:00 Contributed Sessions 8
Statistical Analysis II
Contributed Sessions 9
Statistical Design III
Contributed Sessions 10
Contributed Sessions 11
Study conduct during COVID-19

In-Conference Workshop 3

Anna Heath
Designing Clinical Research to Inform Decision-Making using Value of Information
11:00 - 12:00 Session Proposal 18
Tyler Bonnett
Design and Implementation of Clinical Trials in a Pandemic – Reflecting on the ACTT Studies
Session Proposal 19
Chen Hu
recent developments in quantitative benefit-risk assessment in clinical trials
Session Proposal 20
Laura Levit
It Can Be Done! Equitable, Accessible, and Efficient Clinical Trials Through Streamlined Protocol Designs and Requirements
Contributed Sessions 12
Statistical Analysis III
12:00 - 1:00 Business Meeting with Lunch
1:00 - 2:00 Contributed Sessions 13
Statistical Design IV
Contributed Sessions 14
Statistical Analysis IV
Contributed Sessions 15
Misc I
Contributed Sessions 16
Study Co-ordination III

In-Conference Workshop 4

Yves Rosenberg
Essentials of Clinical Trials
2:00 - 3:00 Session Proposal 21
Dee Blumberg
Challenges and Best Practices for Recruitment and Retention During the COVID Pandemic
Session Proposal 22
Holly Janes
Current issues in the design and analysis of COVID-19 vaccine efficacy trials
Session Proposal 23
Darren Courtney
Choices, choices: Selecting, defining, and measuring outcomes for young people with depressive disorders
Session Proposal 24
Pralay Mukhopadhyay
Challenges with COVID-19 Vaccine Development and Assessing Impact of the Pandemic on Oncology Trial Outcomes
SCT Annual Meeting - Thursday, May 20, 2021
9:30 - 10:00 Pre-recorded talks Q&A - Session 1
10:00 - 11:30 Trial of the Year
11:30 - 12:30 Session Proposal 25
Rema Raman
Impact of the COVID-19 Pandemic on the Design, Operations and Analysis Plans of Dementia Trials
Session Proposal 26
Lehana Thabane
Design and conduct of pilot and feasibility trials: focus on unresolved issues
Session Proposal 27
Thomas Cook
Missing Data in Clinical Trials: principles, planning, prevention
Session Proposal 28
Lauren Balmert
Operational Innovations in Academic Data Analysis and Coordinating Centers
12:30 - 1:00 Lunch
1:00 - 2:00 Contributed Sessions 17
Statistical Design V
Contributed Sessions 18
Data Management II
Contributed Sessions 19
Outcomes II
In-Conference Workshop 5
Stefan Englert
How the estimand addendum to the ICH E9 guideline helps structure clinical objectives, analyses, and conclusions – a series of oncology case studies
In-Conference Workshop 6
Zachary Hallinan
Accelerating evidence generation through quality by design
2:00 - 3:00 Contributed Sessions 20
Misc II
Contributed Sessions 21
Study Co-ordination IV
3:00 - 3:30 Pre-recorded talks Q&A - Session 2
3:00 - 4:00 End of meeting

Frequently | Asked

Have a question? If you do not find the answer in our most frequently asked questions
below, please reach out to us at info@sctweb.org.

The early registration deadline is May 10, 2021 at Midnight Eastern Time.
Please click here to view the list of qualifying countries.
We request that all registrations are paid for online through the secure registration form.
All payments must be made in USD ($) to ensure that the full amount is received.
Credit cards are charged in real time at the time the registration is processed.
Yes. We accept Visa, MasterCard and American Express.

To request an Invitation Letter for the SCT Annual Meeting, please send a request to KellyBurns@sctweb.org after you have completed your registration and received a Meeting Confirmation/Receipt. The letter is subject to approval by office staff and will be sent to you by email.

You must be registered for the Annual Meeting to receive a letter.

Please note that is it your responsibility to check the Visa Entry Regulations into the USA. Further information can be found by clicking here.

If you have not received a receipt, please telephone (847) 427-8010 or email registration@sctweb.org.

Exhibition | Sponsors

If you are interested in becoming a Corporate Sponsor for our 2021 Virtual Annual Meeting, or for more information on the Sponsorship options available, please download the prospectus here or contact us at info@sctweb.org.

Thank You to Our 2020 Corporate Sponsors!

Janssen Research & Development

Platinum Sponsor

Janssen Research & Development

Our mission is to transform individual lives and fundamentally change the way diseases are managed, interpreted, and prevented. We believe that challenging something is the best way to change it.

Gold Sponsor

Frontier Science Foundation

Frontier Science Foundation is a not-for-profit research organization dedicated to the improvement of data management and statistical quality in clinical trials and medical research.

Gold Sponsor

GW Biostatistics Center

The GW Biostatistics Center has a 47 year history of leadership in practice-changing clinical trials and biostatistical methodology research. Center research has been recognized in reports to the US President and Congress and resulted in over 60 NEJM publications.

Gold Sponsor


For more than a century, MSD has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Today, MSD continues to be at the forefront of research to deliver innovative health solutions and advance the prevention and treatment of diseases that threaten people and animals around the world.

Silver Sponsor


Amgen strives to serve patients by transforming the promise of science and biotechnology into therapies that have the power to restore health or save lives. In everything we do, we aim to fulfill our mission to serve patients. And every step of the way, we are guided by the values that define us.

Silver Sponsor

Berry Consultants

Berry Consultants is a statistical consulting company specializing in innovative clinical trial design, Bayesian analysis, adaptive clinical trial execution, and simulation software solutions for the pharmaceutical and medical device industry.

Silver Sponsor

EMMES Corporation

Emmes collaborates with clients to produce valued, trusted scientific research. We are passionate about making a difference in the quality of human health, and have supported more than a thousand studies across a diverse range of diseases since our formation in 1977.

Silver Sponsor

Jaeb Center for Health Research

The Jaeb Center for Health Research was established in 1993 as a freestanding, nonprofit coordinating center for multi-center clinical trials and epidemiologic research. The Jaeb Center's focus is eye disorders or type 1 diabetes.

Silver Sponsor

Oxford Recovery Center

The Oxford Recovery Model develops a targeted healing approach for each unique patient. We employ numerous therapies and healing modalities to treat a wide range of conditions.

Silver Sponsor

University of Wisconsin DCC

The Data Coordinating Center (DCC) is a component of the Clinical Trials Program in the Department of Biostatistics and Medical Informatics at the UW School of Medicine and Public Health. The DCC supports investigator-initiated NIH or industry-sponsored RCTs. We provide expertise in planning, conduct, monitoring, and analysis of clinical trials.

Silver Sponsor

Xeris Pharmaceuticals

Xeris Pharmaceuticals is a specialty pharmaceutical company leveraging novel formulation technology platforms to develop and commercialize ready-to-use, liquid-stable injectables. XeriSol™ and XeriJect™ can lead to products that are easier to use by patients, caregivers, and health practitioners and reduce costs for payers and the healthcare system. Learn more at www.xerispharma.com

Bronze Sponsor

Statistics Collaborative, Inc.

Statistics Collaborative is dedicated to developing research programs with scientific rigor and statistical validity. For more than 30 years, our clients have relied on us for careful thought, meticulous attention to detail, and expertise across a range of statistical methods and therapeutic areas.